Taro Pharmaceutical Industries Ltd. (TARO) Shares Bought by Alps Advisors Inc.

Alps Advisors Inc. raised its holdings in Taro Pharmaceutical Industries Ltd. (NYSE:TARO) by 7.7% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 39,898 shares of the company’s stock after buying an additional 2,861 shares during the period. Alps Advisors Inc. owned about 0.10% of Taro Pharmaceutical Industries worth $4,496,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the business. Bank of Montreal Can increased its stake in shares of Taro Pharmaceutical Industries by 7.5% during the second quarter. Bank of Montreal Can now owns 2,128 shares of the company’s stock worth $238,000 after purchasing an additional 149 shares during the period. NN Investment Partners Holdings N.V. increased its stake in shares of Taro Pharmaceutical Industries by 2.0% during the second quarter. NN Investment Partners Holdings N.V. now owns 53,976 shares of the company’s stock worth $6,049,000 after purchasing an additional 1,064 shares during the period. Creative Planning increased its stake in shares of Taro Pharmaceutical Industries by 3.8% during the second quarter. Creative Planning now owns 7,186 shares of the company’s stock worth $805,000 after purchasing an additional 265 shares during the period. Aperio Group LLC increased its stake in shares of Taro Pharmaceutical Industries by 46.9% during the second quarter. Aperio Group LLC now owns 50,826 shares of the company’s stock worth $5,696,000 after purchasing an additional 16,233 shares during the period. Finally, US Bancorp DE increased its stake in shares of Taro Pharmaceutical Industries by 49.4% during the second quarter. US Bancorp DE now owns 2,983 shares of the company’s stock worth $334,000 after purchasing an additional 986 shares during the period. Hedge funds and other institutional investors own 14.08% of the company’s stock.

Shares of Taro Pharmaceutical Industries Ltd. (TARO) traded down $0.11 during trading hours on Friday, reaching $117.57. The company had a trading volume of 65,200 shares, compared to its average volume of 122,339. The firm has a market capitalization of $4,763.11, a P/E ratio of 14.48 and a beta of 0.65. Taro Pharmaceutical Industries Ltd. has a 1-year low of $94.00 and a 1-year high of $128.46.

WARNING: “Taro Pharmaceutical Industries Ltd. (TARO) Shares Bought by Alps Advisors Inc.” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2017/11/12/taro-pharmaceutical-industries-ltd-taro-shares-bought-by-alps-advisors-inc.html.

A number of equities research analysts recently issued reports on TARO shares. TheStreet downgraded Taro Pharmaceutical Industries from a “b-” rating to a “c+” rating in a research report on Wednesday, August 9th. BidaskClub downgraded Taro Pharmaceutical Industries from a “buy” rating to a “hold” rating in a research report on Sunday, July 16th.

About Taro Pharmaceutical Industries

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Want to see what other hedge funds are holding TARO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Taro Pharmaceutical Industries Ltd. (NYSE:TARO).

Institutional Ownership by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

Receive News & Ratings for Taro Pharmaceutical Industries Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply